Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]

Background In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation’s decision to recomme...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Wellcome Open Research
المؤلفون الرئيسيون:	Mark D. Lyttle, Helen Groves, Thomas C. Williams, Simon B. Drysdale, Ian Sinha, Xinxue Liu, Steve Cunningham, Dalia Iskander, Abigail Maxwell-Hodkinson, Shaun O'Hagan, Olivia V. Swann, Chengetai D. Mpamhanga, Damian Roland, Thomas Waterfield, Robin Marlow
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wellcome 2024-12-01
الموضوعات:	COVID-19 Respiratory Syncytial Virus Bronchiolitis Infants Children Palivizumab eng
الوصول للمادة أونلاين:	https://wellcomeopenresearch.org/articles/6-120/v4